4Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
5Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic resona- nce imaging/ultrasound fusion guided prostate biopsy improv- es cancer detection following transrectal ultrasound biopsy and correlates with muhiparametric magnetic resonance imag- ing[J]. J Urol, 2011, 186(4): 1281-1285.
6Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for p- rediction of tumor site, tumor size, and local extension of prost- ate cancer[J]. Urology, 2004, 64(1): 101-105.
7Pickles MD, Gibbs P, Sreenivas M, et al. Diffusion-weighted i- maging of normal and malignant prostate tissue at 3.0 T[J]. J Magn Reson Imaging, 2006, 23(2): 130-134.
8Ren J, Huan Y, Wang H, et al. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases [J]. Abdom Imaging, 2008, 33(6): 724-728.
9Kurhanewicz J, Vigneron D, Carroll P, et al. Muhiparametricm- agnetic resonance imaging in prostate cancer: present and futu- re[J]. Curr Opin Urol, 2008, 18(1): 71- 77.
10Katahira K, Takahara T, Kwee TC, et al. Uhra-high-b-value diffusion-weighted MR imaging for the detection of prostate c- ancer: evaluation in 201 cases with histopathological correl- ation [J]. Eur Radiol, 2011, 21(1): 188-196.
